Bromley, Susan E.
Matthews, Anthony
Smeeth, Liam
Stanway, Susannah
Bhaskaran, Krishnan
Funding for this research was provided by:
Sir Henry Dale Fellowship and Welcome Trust (107731/Z/15/Z)
Article History
Received: 25 March 2019
Accepted: 28 June 2019
First Online: 18 July 2019
Change Date: 22 October 2019
Change Type: Correction
Change Details: The article Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK, written by Susan E. Bromley, was originally published electronically on the publisher’s internet portal.
Compliance with ethical standards
: The protocol for this study was approved by the Medicines and Healthcare products Regulatory Agency Independent Scientific Advisory Committee (reference 17–122), and the study was approved by the London School of Hygiene and Tropical Medicine MSc Ethics Committee (reference 13465). Participant consent is not required for ISAC approved CPRD studies using purely observational data.
: The authors declare that they have no conflict of interest.